RayKnowChina Research Map
Shortlist0

Guangzhou

Fuda Cancer Hospital

广州复大肿瘤医院

Listed for 3 of the 53 diseases this site covers, from the research papers it led and the trials registered with it as lead sponsor or site.

Research activity in public records, not a rating of care. Whether the hospital can help a particular patient is for the hospital and the treating doctor to say.

No official website checked for this hospital yet.

Getting in touch

Research at Fuda Cancer Hospital

Choose a disease to see the papers and trials behind it. Each tile shows papers led, 2021–2025, and papers per year.

Only the 53 diseases this site covers. A disease it is not listed for means this hospital did not meet the listing rule for that disease in these records; it does not mean the hospital does not treat it. Which hospitals are listed

  1. Nasopharyngeal carcinoma鼻咽癌0 papers led
  2. Hepatocellular carcinoma肝细胞癌0 papers led
  3. Stomach cancer胃癌0 papers led

Not listed for: Oesophageal squamous cell carcinoma, Hepatoblastoma, Retinoblastoma, Chordoma, Osteosarcoma, Gastrointestinal stromal tumour, Neuroblastoma, Ewing sarcoma, Multiple myeloma, B-cell acute lymphoblastic leukaemia, Aplastic anaemia, Haemophagocytic lymphohistiocytosis, Beta thalassaemia, Haemophilia A, Atypical haemolytic uraemic syndrome, Thrombotic thrombocytopenic purpura, Fanconi anaemia, Neuromyelitis optica spectrum disorder, IgG4-related disease, Myasthenia gravis, Moyamoya disease, Wilson disease, Biliary atresia, Anti-NMDA receptor encephalitis, Takayasu arteritis, Hepatic echinococcosis, Idiopathic pulmonary fibrosis, Lymphangioleiomyomatosis, Amyotrophic lateral sclerosis, Spinal muscular atrophy, Fabry disease, Pompe disease, Duchenne muscular dystrophy, Behçet disease, Alport syndrome, IgA nephropathy, Gaucher disease, Niemann–Pick disease type C, Osteogenesis imperfecta, Primary biliary cholangitis, Primary sclerosing cholangitis, Congenital diaphragmatic hernia, Hirschsprung disease, Inherited epidermolysis bullosa, Hereditary angioedema, Familial adenomatous polyposis, Leber hereditary optic neuropathy, Majeed syndrome, NGLY1 deficiency, ISG15 deficiency.

Cancer

Nasopharyngeal carcinoma

鼻咽癌

Led no English-language PubMed papers on nasopharyngeal carcinoma in 2021–2025. Its linked research records are below.

Papers led
0
2021–2025
Trials led
3
any status, ClinicalTrials.gov
Open trials led
0
recruiting or about to
Open trials as a site
0
led by another institution

23 hospitals in Guangzhou for nasopharyngeal carcinoma176 hospitals in China for nasopharyngeal carcinoma

No open trial on nasopharyngeal carcinoma lists this hospital on ClinicalTrials.gov on 8 Nov 2026.

The records behind these numbers

Hospital name read automatically from author addresses, not yet checked by hand.

All its trials on ClinicalTrials.gov, any status3
  1. High-activity Natural Killer Immunotherapy for Small Metastases of Nasopharyngeal CancerCompletedNCT03007836Lead sponsorPhase 1/Phase 2Start 2016-12
  2. HepaSphere Interventional Therapy Using Digital Subtraction Angiography(DSA) for Nasopharyngeal CarcinomaCompletedNCT02523430Lead sponsorPhase 1/Phase 2Start 2015-05
  3. The Immunotherapy of Nasopharyngeal Cancer Using Cancer Stem Cells VaccineCompletedNCT02115958Lead sponsorPhase 1/Phase 2Start 2014-03

Run the PubMed searchClinicalTrials.gov

Cancer

Hepatocellular carcinoma

肝细胞癌

Led no English-language PubMed papers on hepatocellular carcinoma in 2021–2025. Its linked research records are below.

Papers led
0
2021–2025
Trials led
9
any status, ClinicalTrials.gov
Open trials led
0
recruiting or about to
Open trials as a site
0
led by another institution

14 hospitals in Guangzhou for hepatocellular carcinoma192 hospitals in China for hepatocellular carcinoma

No open trial on hepatocellular carcinoma lists this hospital on ClinicalTrials.gov on 8 Nov 2026.

The records behind these numbers

Hospital name read automatically from author addresses, not yet checked by hand.

All its trials on ClinicalTrials.gov, any status9
  1. Combination of PD-1 and VEGFR-2 Blockade for Advanced Hepatocellular CarcinomaCompletedNCT04393220Lead sponsorPhase 2Start 2020-05
  2. PENS or TENS for Pain in Liver CancerCompletedNCT03338543Lead sponsorN/AStart 2017-11
  3. Combination of Cryosurgery and NK Immunotherapy for Tumors in Transplanted LiverCompletedNCT02849015Lead sponsorPhase 1/Phase 2Start 2016-07
  4. Combination of Irreversible Electroporation and NK Immunotherapy for Recurrent Liver CancerCompletedNCT03008343Lead sponsorPhase 1/Phase 2Start 2016-12
  5. Percutaneous Irreversible Electroporation for Unresectable Hepatic Carcinoma in Poor Liver FunctionCompletedNCT02352935Lead sponsorN/AStart 2015-01
  6. Percutaneous Irreversible Electroporation to Treat Liver Cancer Close to the GallbladderCompletedNCT02332551Lead sponsorN/AStart 2015-01
  7. Nano Drug Interventional Therapy Using Digital Subtraction Angiography(DSA) for Liver CarcinomaCompletedNCT02449109Lead sponsorPhase 1/Phase 2Start 2015-05
  8. CAR-T Cell Immunotherapy for HCC Targeting GPC3WithdrawnNCT02723942Lead sponsorPhase 1/Phase 2Start 2015-06
  9. Cancer Stem Cells Vaccine Therapy in Treating Hepatocellular Cancer PatientsCompletedNCT02089919Lead sponsorPhase 1/Phase 2Start 2014-02

Run the PubMed searchClinicalTrials.gov

Cancer

Stomach cancer

胃癌

Led no English-language PubMed papers on stomach cancer in 2021–2025. Its linked research records are below.

Papers led
0
2021–2025
Trials led
3
any status, ClinicalTrials.gov
Open trials led
0
recruiting or about to
Open trials as a site
0
led by another institution

16 hospitals in Guangzhou for stomach cancer218 hospitals in China for stomach cancer

No open trial on stomach cancer lists this hospital on ClinicalTrials.gov on 8 Nov 2026.

The records behind these numbers

Hospital name read automatically from author addresses, not yet checked by hand.

All its trials on ClinicalTrials.gov, any status3
  1. Study of Activated Cytokine-induced Killer Armed With Bispecific Antibody for Advanced Gastric CancerWithdrawnNCT03554395Lead sponsorPhase 2Start 2018-04
  2. Bioinformation Therapy for Gastric CancerCompletedNCT03350477Lead sponsorPhase 2/Phase 3Start 2017-11
  3. Irreversible Electroporation(IRE) For Unresectable Stomach NeoplasmsCompletedNCT02430636Lead sponsorN/AStart 2015-01

Run the PubMed searchClinicalTrials.gov

Getting in touch

Name card to show staff or a driver

广州复大肿瘤医院

Fuda Cancer Hospital

广州

Large hospitals often have several campuses. Confirm the campus with the hospital before travelling.

Inquiry letter in English and Chinese

Fill in the brackets, then send it through the contact options on the hospital's international office or official website. Nothing typed here leaves this device.

Records hospitals usually ask for

  • A recent summary or letter from the treating doctor
  • Pathology report
  • Scans (CT, MRI, PET) with their reports, and the images if possible
  • Treatments so far, with dates
  • Current medicines

What to do next

Talk with the treating doctorThis page can be shared with the treating doctor to discuss whether this team's work is relevant.
Check the team is still therePapers lag by months and doctors move. Look for the department on the hospital's own website.
Contact the hospital directlyUse the hospital's own contacts. Hospitals never pay us, and each hospital decides which patients it accepts.

Where these numbers come from

Papers

English-language PubMed papers whose first or last author lists this hospital as their first affiliation, 2021–2025. Definitions

Trials

ClinicalTrials.gov records naming this hospital as lead sponsor or site, as of 8 Nov 2026.

Identifiers and other names

ROR Wikidata
Fuda Cancer Hospital

Suggest a correctionDownload the data